Nurse Practitioner in Belington, WV Accepting Medicare

5 Nurse Practitioner nurses found. Showing 1 - 5

Rhonda Ann Parker, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 70 N Sturmer St, Belington, WV 26250 Phone: 304-823-2800

Mrs. Mary Alice Milnes, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 210 N Sturmer St, Belington, WV 26250 Phone: 304-823-2800    Fax: 304-823-2803

Donna Lee March, MSN: NP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 70 N Sturmer St, Belington, WV 26250 Phone: 304-823-2800    Fax: 304-823-2703

Loretta J Wilson, CFNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 70 N Sturmer St, Belington, WV 26250 Phone: 304-823-2800    Fax: 304-823-2703

Amy R Rollins, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 342 Joseph Chapel Rd, Belington, WV 26250 Phone: 304-841-2440

News Archive

Study looks at trends in added sugars consumption by infants and toddlers

A new study in the Journal of the Academy of Nutrition and Dietetics, published by Elsevier, found that nearly two-thirds of infants (61 percent) and almost all toddlers (98 percent) consumed added sugars in their average daily diets, primarily in the form of flavored yogurts (infants) and fruit drinks (toddlers). Infants were 6-11 months, and toddlers were 12-23 months.

Australian study: Many home blood pressure monitors not validated for accuracy

Home monitoring blood pressure devices may not be accurate and could lead to misdiagnoses and inappropriate treatment.

Oncolytics Biotech receives U.K. MHRA approval for REOLYSIN combination Phase 3 trial

Oncolytics Biotech Inc. today announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that the Company previously reached an agreement on with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process.

Researchers identify enzyme that controls spread of breast cancer

Researchers at the University of California, San Diego School of Medicine have identified an enzyme that controls the spread of breast cancer. The findings, reported in the current issue of PNAS, offer hope for the leading cause of breast cancer mortality worldwide.

Read more Medical News

› Verified 2 days ago